Using umbilical cord tissue to detect fetal exposure to illicit drugs: A multicentered study in Utah and New Jersey

Journal of Perinatology

Volumn 28, Issue 11, 2008, Pages 750-753

  Montgomery, D P ^a,b   Plate, C A ^c   Jones, M ^c   Jones, J ^c   Rios, R ^c   Lambert, D K ^a,b   Schumtz, N ^a,b   Wiedmeier, S E ^a,d,e,f   Burnett, J ^a,d   Ail, S ^f   Brandel, D ^f   Maichuck, G ^f   Durham, C A ^a,g   Henry, E ^h   Christensen, R D ^a,b  

^a Intermountain Healthcare ^*  (United States)

^b McKay Dee Hospital Center   (United States)

^c US Drug Testing Laboratories   (United States)

^d LDS HOSPITAL   (United States)

^e INTERMOUNTAIN MEDICAL CENTER   (United States)

^f UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^g Logan Regional Hospital   (United States)

^h Institute for Healthcare Delivery Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID; COCAINE; ILLICIT DRUG; METHAMPHETAMINE; OPIATE; PHENCYCLIDINE;

ARTICLE; CONTROLLED STUDY; DRUG ABUSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FETUS; GAS CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LIQUID CHROMATOGRAPHY; MECONIUM; PRENATAL EXPOSURE; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY; UMBILICAL CORD; UNITED STATES;

ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFANT, NEWBORN; MASS SPECTROMETRY; NEW JERSEY; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; ROC CURVE; STREET DRUGS; SUBSTANCE ABUSE DETECTION; UMBILICAL CORD; UTAH;

EID: 55749093088     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/jp.2008.97     Document Type: Article

References (22)

1. Montgomery D, Plate C, Alder SC, Jones M, Jones J, Christensen RD. Testing for fetal exposure to illicit drugs using umbilical cord tissue vs meconium. J Perinatol 2006; 26: 11-14.
2. Le NL, Reiter A, Tomlinson K, Jones J, Moore C. The detection of oxycodone in meconium specimens. J Anal Toxicol 2005; 29: 54-57.
3. Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: A fundamental evaluation tool in clinical medicine. Clin Chem 1993; 39: 561-577.
4. Addis A, Moretti ME, Ahmed SF, Einarson TR, Koren G. Fetal effects of cocaine: An updated meta-analysis. Reprod Toxicol 2001; 15: 341-369.
5. Church MW, Morback CA, Subramanian MG. Comparative effects of prenatal cocaine, alcohol, and undernutrition on maternal/fetal toxicity and fetal body composition in the Sprague-Dawley rat with observations on strain-dependent differences. Neurotoxicol Teratol 1995; 17: 559-567.
6. Fried RA, Watkinson B. 36- and 48-month neurobehavioral follow-up of children prenatally exposed to marijuana, cigarettes, and alcohol. J Dev Behav Pediatr 1990; 11: 49-58.
7. Goldschmidt L, Day NL, Richardson GA. Effects of prenatal marijuana exposure on child behavior problems at age 10. Neurotoxicol Teratol 2000; 22: 325-336.
8. Oro AS, Dixon SD. Perinatal cocaine and methamphetamine exposure: maternal and neonatal correlates. J Pediatr 1987; 111: 571-578.
9. Plessinger MA. Prenatal exposure to amphetamines. Risks and adverse outcomes in pregnancy. Obstet Gynecol Clin North Am 1998; 25 119-138.
10. Dixon SD, Bejar R. Echoencephalographic findings in neonates associated with maternal cocaine and methamphetamine use: Incidence and clinical correlates. J Pediatr 1989; 115: 770-778.
11. Gareri J, Klein J, Koren G. Drugs of abuse testing in meconium. Clinica Chimica Acta 2006; 366: 101-111.
12. Ostrea Jr EM, Brady MJ, Parks PM, Asensio DC, Naluz A. Drug screening of meconium in infants of drug-dependent mothers: An alternative to urine testing. J Pediatr 1989; 115: 474-477.
13. Ostrea Jr EM, Romero A, Yee H. Adaptation of the meconium drug test for mass screening. J Pediatr 1993; 122: 152-154.
14. Moore C, Negrusz A, Lewis D. Determination of drugs of abuse in meconium. J Chromatogr B Biomed Sci Appl 1998; 713: 137-146.
15. Ostrea Jr EM, Brady M, Gause S, Raymundo AL, Stevens M. Drug screening of newborns by meconium analysis: A large-scale, prospective, epidemiologic study. Pediatrics 1992; 89: 107-113.
16. Moriya F, Chan KM, Noguchi TT, Wu PY. Testing for drugs of abuse in meconium of newborn infants. J Anal Toxicol 1994; 18: 41-45.
17. Ostrea Jr EM, Knapp DK, Tannenbaum L, Ostrea AR, Romero A, Salari V et al. Estimates of illicit drug use during pregnancy by maternal interview, hair analysis, and meconium analysis. J Pediatr 2001; 138: 344-348.
18. Bar-Oz B, Klein J, Karaskov T, Koren G. Comparison of meconium and neonatal hair analysis for detection of gestational exposure to drugs of abuse. Arch Dis Child Fetal Neonatal Ed 2003; 88: F98-F100.
19. Vinner E, Vignau J, Thibault D, Codaccioni X, Brassart C, Humbert L et al. Neonatal hair analysis contribution to establishing a gestational drug exposure profile and predicting a withdrawal syndrome. Ther Drug Monit 2003; 25: 421-432.
20. Garcia-Bournissen F, Rokach B, Karaskov T, Koren G. Cocaine detection in maternal and neonatal hair: Implications to fetal toxicology. Ther Drug Monit 2007; 29: 71-76.
21. Ostrea Jr EM, Romero A, Knapp DK, Ostrea AR, Lucena JE, Utarnachitt RB. Postmortem drug analysis of meconium in early-gestation human fetuses exposed to cocaine: Clinical implications. J Pediatr 1994; 124 477-479.
22. Silvestre MA, Lucena JE, Roxas Jr R, Evangelista ES, Ostrea Jr EM. Effects of timing, dosage, and duration of morphine pregnancy on the amount of morphine in meconium in a rat model. Biol Neonate 1997; 72: 112-117.